Covid-19: AstraZeneca examining impact of new variant on its vaccine, antibody cocktail Ruchika Sharma27 Nov 2021 3:49 PM ISTLondon: AstraZeneca said on Friday it was examining the impact of a new coronavirus variant that is spreading rapidly in South Africa on its...
AstraZeneca's antibody shot 83% effective at preventing Covid MD Bureau21 Nov 2021 10:00 AM ISTLondon: A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent capable to reduce the risk of...
AstraZeneca begins to earn mild profit from Covid-19 vaccine Ruchika Sharma15 Nov 2021 3:37 PM ISTNew Delhi: AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the...
AstraZeneca to transfer Eklira, Duaklir rights to Covis Pharma for USD 270 million Ruchika Sharma5 Nov 2021 9:00 AM ISTUK: AstraZeneca has recently announced that the company has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in...
AstraZeneca launches clinical data, insights division in India Ruchika Sharma20 Oct 2021 5:02 PM ISTNew Delhi: AstraZeneca India Private Limited, the Global Capability Centre (GCC) of AstraZeneca has launched a clinical data and insights division in...
Russia rebuffs claims of stealing AstraZeneca COVID vaccine formula MD Bureau14 Oct 2021 12:57 PM ISTNew York: Russia has rebuffed accusations that its spies stole the "blueprint" for the Oxford-AstraZeneca vaccine and used it to create its own...
AstraZeneca tixagevimab, cilgavimab cocktail shows positive result in Covid-19 trial MD Bureau12 Oct 2021 10:00 AM ISTLondon: AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on...
USFDA grants Orphan Drug Designation to AstraZeneca Tezepelumab Ruchika Sharma11 Oct 2021 1:04 PM ISTUK: AstraZeneca has announced that Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for...
AstraZeneca seeks USFDA authorization for Covid-19 Prophylaxis drug AZD7442 Ruchika Sharma6 Oct 2021 2:13 PM ISTUK: AstraZeneca has submitted a request to the US Food and Drug Administration (USFDA) for an Emergency Use Authorization (EUA) for AZD7442, its...
AstraZeneca Covid-19 vaccine shows 74 percent efficacy in US trial Ruchika Sharma2 Oct 2021 10:00 AM ISTChicago: AstraZeneca Plc's COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people...
AstraZeneca Pharma India bags DCGI nod to import and market Selumetinib capsules Ruchika Sharma27 Sept 2021 4:02 PM ISTNew Delhi: Drugmaker, AstraZeneca Pharma India Limited, has recently announced that the company has received import and market permission in Form...
India may allow to minimise gap between Covishield doses sold privately: Report Ruchika Sharma24 Sept 2021 10:45 AM ISTNew Delhi: India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line...
